Cumberland Pharmaceuticals Inc.: 10-Q filed 2011-11-07
What Cumberland Pharmaceuticals Inc. reported in its quarterly report filed 2011-11-07 (fiscal Q3 2011): 36 published measures, 98 facts as tagged in accession 0000950123-11-096010.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-07
- Fiscal period
- fiscal Q3 2011
- Accession
- 0000950123-11-096010 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cumberland Pharmaceuticals Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 96,078,666 | USD | |
| At 2010-12-31 | 92,054,054 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 12,621,609 | USD | |
| At 2010-12-31 | 14,338,579 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 83,547,065 | USD | |
| At 2010-12-31 | 77,777,680 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 71,074,807 | USD | |
| At 2010-12-31 | 65,893,970 | USD | |
| At 2010-09-30 | 65,518,340 | USD | |
| At 2009-12-31 | 78,701,682 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,847,412 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 4,746,191 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,008,244 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,619,126 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 7,692,058 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 1,033,102 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 241,885 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 311,301 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -2,128,980 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -13,773,096 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -382,241 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -443,348 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 11,744,997 | USD | |
| At 2010-12-31 | 6,998,806 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 20,327,537 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 20,414,593 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 20,327,867 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 20,335,911 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 20,534,647 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 20,657,567 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 20,803,182 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 21,135,762 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0.09 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | 0.23 | USD/shares | 273 |
| 2010-07-01 to 2010-09-30 | 0.05 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | 0.08 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0.09 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | 0.23 | USD/shares | 273 |
| 2010-07-01 to 2010-09-30 | 0.05 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | 0.08 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,278,472 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 3,238,421 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 943,141 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,529,339 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,198,805 | USD | |
| At 2010-12-31 | 1,220,010 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 467,850 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 503,446 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 3,098,360 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 8,138,218 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 2,443,857 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 4,264,225 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 85,878,391 | USD | |
| At 2010-12-31 | 81,038,842 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 33,390 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 329,037 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 547,795 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,299,703 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 7,453,231 | USD | |
| At 2010-12-31 | 9,227,620 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 3,280,289 | USD | |
| At 2010-12-31 | 2,124,654 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 7,029,186 | USD | |
| At 2010-12-31 | 7,427,223 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 4,505,411 | USD | |
| At 2010-12-31 | 5,145,494 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 2,884,540 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 4,129,648 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 6,874,599 | USD | |
| At 2010-12-31 | 7,683,842 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,233,025 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 3,269,746 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,138,955 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 2,947,623 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 20,215,910 | shares | |
| At 2010-12-31 | 20,338,461 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 83,457,057 | USD | |
| At 2010-12-31 | 77,715,475 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,972,284 | USD | |
| At 2010-12-31 | 2,367,979 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,838,957 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 4,718,388 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,001,596 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,594,871 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 2,117,684 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 6,442,139 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,806,975 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 5,471,012 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 801,483 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 723,687 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 171,727 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 515,180 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 171,732 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 515,184 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -640,083 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -1,384,903 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -809,243 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 2,823,355 | USD | 273 |
Inspect the source
- Entity
- Cumberland Pharmaceuticals Inc. / CIK 0001087294
- Captured
- 2026-09-20T05:21:29.619Z
- SEC response SHA-256
b37ed2fef35db1cde0c40b2233eb97cf370fc96d41a5c7d61b6a5a76a296e4a0
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001087294.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))